SCHEMBL4826504

SCHEMBL4826504

O=C(Nc1cc(OCCCON=Cc2ccc(C(F)(F)F)cc2)ccc1C(=O)O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTDSP1 Q9GZU7 1/20 0.50
PLK1 P53350 5/20 0.49
KCNK2 O95069 3/20 0.46
KCNK10 P57789 3/20 0.46
KMT2A Q03164 3/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
PPARA Q07869 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HTT P42858 1/20 0.41
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
MEN1 O00255 1/20 0.41
PKM P14618 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TRPA1 O75762 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.40
SPHK2 Q9NRA0 1/20 0.40
SPHK1 Q9NYA1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826497 1.00 CTDSP1 (0.50) CTDSP1PLK1KCNK2KCNK10KMT2A
SCHEMBL4827015 0.96 CTDSP1 (0.46) CTDSP1PLK1KCNK2KCNK10KMT2A
SCHEMBL4827028 0.96 CTDSP1 (0.46) CTDSP1PLK1KCNK2KCNK10KMT2A
SCHEMBL4829109 0.95 CTDSP1 (0.46) CTDSP1PLK1KCNK2KCNK10KMT2A
SCHEMBL4829116 0.95 CTDSP1 (0.46) CTDSP1PLK1KCNK2KCNK10KMT2A
SCHEMBL4825675 0.95 ACLY (0.47) CTDSP1PLK1KCNK2KCNK10KMT2A
SCHEMBL4825688 0.95 ACLY (0.47) CTDSP1PLK1KCNK2KCNK10KMT2A
SCHEMBL4833312 0.91 PLK1 (0.52) PLK1KCNK2KCNK10KMT2ANPC1
SCHEMBL4833302 0.91 PLK1 (0.52) PLK1KCNK2KCNK10KMT2ANPC1
SCHEMBL4828804 0.90 PLK1 (0.44) CTDSP1PLK1KCNK2KCNK10PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7420083-B2 Substituted aryloximes WYETH (US) 2008-09-02 US claimed
US-20050070584-A1 Substituted aryloximes WYETH (US) 2005-03-31 US claimed
US-20080293790-A1 SUBSTITUTED ARYL OXIMES WYETH (US) 2008-11-27 US disclosed
US-7420083-B2 Substituted aryloximes WYETH (US) 2008-09-02 US disclosed
US-20050070584-A1 Substituted aryloximes WYETH (US) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070584-A1 Substituted aryloximes AHR, NQO1, AOX1 CTDSP1 2943/4885PLK1 3639/4885KCNK2 3034/4885
US-20080293790-A1 SUBSTITUTED ARYL OXIMES HCCS, AOX1, TET2 CTDSP1 2524/4885PLK1 4185/4885KCNK2 3548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.